Medical Oncology, Год журнала: 2025, Номер 42(5)
Опубликована: Апрель 2, 2025
Язык: Английский
Medical Oncology, Год журнала: 2025, Номер 42(5)
Опубликована: Апрель 2, 2025
Язык: Английский
Journal of Medicinal Chemistry, Год журнала: 2025, Номер unknown
Опубликована: Фев. 12, 2025
Covalent-allosteric inhibitors (CAIs) may achieve the best of both worlds: increased potency, long-lasting effects, and reduced drug resistance typical covalent ligands, along with enhanced specificity decreased toxicity inherent in allosteric modulators. Therefore, CAIs can be an effective strategy to transform many undruggable targets into druggable ones. However, are challenging design. In this perspective, we analyze discovery known targeting three protein families: phosphatases, kinases, GTPases. We also discuss how computational methods tools play a role addressing practical challenges rational CAI
Язык: Английский
Процитировано
0Medical Oncology, Год журнала: 2025, Номер 42(5)
Опубликована: Апрель 2, 2025
Язык: Английский
Процитировано
0